CAMBRIDGE, Mass.--(BUSINESS WIRE)--Omega Therapeutics™, a company pioneering a new category of genomic medicine through epigenomic programming, today announced the completion of an $85 million ...
The ability of body cells to "turn on" and "turn off" selected genes, changing what they look like and what they do, forms the basis of cellular programming, an emerging approach in regenerative ...
Scientists have discovered a set of proteins, AJSZ, that can be used for cellular programming, allowing them to reprogram damaged cardiac cells to mend heart lesions in mice after a heart attack AJSZ ...
Altos Labs commits to funding four CiRA research projects for five years SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- Altos Labs (Altos) today announced that it has signed a sponsored research ...
The earliest days after fertilization, once a sperm cell meets an egg, are shrouded in scientific mystery. The process of how a humble single cell becomes an organism fascinates scientists across ...
Cas9 is an RNA-guided endonuclease that is directed to a specific DNA sequence through complementarity between the associated guide RNA (gRNA) and its target locus 1,2. Cas9 can be directed to nearly ...
I've got a problem that I think would be interesting to approach using a cellular programming language. I've been poking around the nets, but about all I can find is CELLAR, and I can't find an ...
“ Although human cells all share a common genetic code within their 23 pairs of chromosomes, epigenetic regulation determines identity and function at the tissue and cellular level. Coordinated ...
Scientists have identified a group of proteins to leverage for cellular programming, enabling them to reprogram damaged heart cells to repair heart injuries in mice following a heart attack. The ...
SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- Altos Labs (Altos) today announced that it has signed a sponsored research agreement with the Center for iPS Cell Research and Application (CiRA) at Japan's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback